Announcements Trials
Browse Landscape

Phase

Phase 2 212Phase 3 123Phase 1 118Phase 1/2 78Phase 2/3 13Phase EARLY_PHASE1 8Phase NA 4Phase 4 1

Status

Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Genitourinary 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Recurrence 1Peripheral Nervous System Diseases 1Mouth Neoplasms 1Lung Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Standard of Care 70Educational Status 60Interviews as Topic 54Methods 53Practice Guidelines as Topic 52Early Intervention, Educational 49Blood Specimen Collection 48Exercise 47Surveys and Questionnaires 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Radiosurgery 28Palliative Care 22Radiotherapy 20Resistance Training 17Biopsy 17Patient Navigation 16Magnetic Resonance Imaging 15Diet Therapy 13Counseling 13Health Promotion 12Exercise Test 12Therapeutics 10Surgical Procedures, Operative 10Telemedicine 9Restraint, Physical 9Nutrition Assessment 9Genetic Testing 9X-Rays 8Radiation Dose Hypofractionation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × pembrolizumab × 90 days × Clear all
NCT07629700 2026-06-05

ENDEAVOR

University of Florence

Phase NA Not yet recruiting
40 enrolled
Genitourinary

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases

NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07343596 2026-04-22

Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery

University of Wisconsin, Madison

Phase NA Recruiting
20 enrolled
Head & Neck

Mouth Neoplasms

NCT05047094 2026-04-06

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Alpha Tau Medical LTD.

Phase NA Recruiting
48 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡